By Dan Weil Health insurance and info tech companies are sitting at ‘inflection points’ with shares poised for gains of 25% to 100%, bank says. Credit Suisse has selected stocks that it sees at “inflection points,” with catalysts occurring that will drive them higher. “We have focused on those stocks where there is an identifiable inflection point or catalyst looming in 2022 to either provide another leg to existing momentum or signal a turning point,” bank staffers wrote in a commentary cited by CNBC. The U.S. stocks they chose include health insurance company Humana (HUM) – Get Humana Inc. R…